Mucormycosis: An emerging concern of orofacial complication in COVID-19 infection
Coronavirus disease (COVID-19) infection has been seen to be associated with secondary bacterial and fungal infections. Mucormycosis has been increasingly reported in patients with COVID-19 infection, especially those with underlying medical conditions such as diabetes mellitus and on steroid therap...
Main Authors: | Anam Mushtaq, Reshi Iram Shafi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Oral Research and Review |
Subjects: | |
Online Access: | http://www.jorr.org/article.asp?issn=2249-4987;year=2022;volume=14;issue=2;spage=161;epage=164;aulast=Mushtaq |
Similar Items
-
COVID-19-associated mucormycosis and treatments
by: Vetriselvan Subramaniyan, et al.
Published: (2021-01-01) -
Resurgence of mucormycosis during COVID-19 pandemic
by: Kamran Ali, et al.
Published: (2022-06-01) -
Mucormycosis in COVID-19 patients
by: Natarajan Sundaram, et al.
Published: (2021-01-01) -
Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms
by: A. E. Babushkin, et al.
Published: (2024-07-01) -
Mucormycosis: An Epidemic Complicating the COVID-19 Pandemic
by: Shalaka Khade, et al.
Published: (2023-05-01)